[HTML][HTML] Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

D Accapezzato, V Francavilla, M Paroli… - The Journal of …, 2004 - Am Soc Clin Investig
D Accapezzato, V Francavilla, M Paroli, M Casciaro, LV Chircu, A Cividini, S Abrignani
The Journal of clinical investigation, 2004Am Soc Clin Investig
Regulatory T (TR) cells consist of phenotypically and functionally distinct CD4+ and CD8+ T
cell subsets engaged both in maintaining self-tolerance and in preventing anti–non-self
effector responses (microbial, tumor, transplant, and so on) that may be harmful to the host.
Here we propose that the proinflammatory function of virus-specific memory effector CCR7–
CD8+ T cells, which are massively recruited in the liver, are inefficient (in terms of IFN-γ
production) in patients with chronic hepatitis C virus (HCV) infection because of the …
Regulatory T (TR) cells consist of phenotypically and functionally distinct CD4+ and CD8+ T cell subsets engaged both in maintaining self-tolerance and in preventing anti–non-self effector responses (microbial, tumor, transplant, and so on) that may be harmful to the host. Here we propose that the proinflammatory function of virus-specific memory effector CCR7CD8+ T cells, which are massively recruited in the liver, are inefficient (in terms of IFN-γ production) in patients with chronic hepatitis C virus (HCV) infection because of the concomitant presence of virus-specific CCR7CD8+ TR cells producing considerable amounts of IL-10. These CD8+ TR cells are antigen specific, as they can be stimulated by HCV epitopes and suppress T cell responses that are in turn restored by the addition of neutralizing anti–IL-10. This study provides for the first time to our knowledge direct evidence of the existence of virus-specific CD8+ TR cells that infiltrate the livers of patients with chronic HCV infection, identifies IL-10 as a soluble inhibitory factor mediating suppression, and suggests that these cells play a pivotal role in controlling hepatic effector CD8+ T cell responses.
The Journal of Clinical Investigation